BREVIBLOC Safety Questions, BREVIBLOC Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about BREVIBLOC. Our extensive database of BREVIBLOC adverse events and BREVIBLOC warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about BREVIBLOC
BREVIBLOC Safety Reports
Total BREVIBLOC reports: 12.BREVIBLOC FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 2.
Take BREVIBLOC Side Effects Survey or Share Your BREVIBLOC Story. BREVIBLOC Usage.
Consumer or non-health professional from FRANCE reported BREVIBLOC problem on Apr 16, 2007. Female patient, 55 years of age, was diagnosed with echocardiogram and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: lip oedema, oedema mouth. BREVIBLOC dosage: unknown. During the same period patient was treated with DOBUTAMINE, ATROPINE. Patient was hospitalized. Patient recovered.
BREVIBLOC problem was reported by a Pharmacist from UNITED STATES on Sept 11, 2006. Female patient, 36 years of age, was diagnosed with blood pressure increased and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: necrosis, phlebitis. BREVIBLOC dosage: unknown. Patient recovered.
Consumer or non-health professional from JAPAN reported BREVIBLOC problem on June 01, 2007. Male patient, 60 years of age, weighting 145.5 lb, was diagnosed with tachycardia, blood pressure increased and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. BREVIBLOC dosage: unknown. During the same period patient was treated with NEOSTIGMINE, DIGOXIN, AMLODIPINE, LOSARTAN POTASSIUM, FAMOTIDINE, NATEGLINIDE, ACARBOSE. Patient recovered.
BREVIBLOC problem was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Male patient, 60 years of age, was diagnosed with blood pressure increased and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. BREVIBLOC dosage: unknown. During the same period patient was treated with NEOSTIGMINE, DIGOXIN, AMLODIPINE, LOSARTAN, FAMOTIDINE, NATEGLINIDE, ACARBOSE, NICARDIPINE HYDROCHLORIDE. Patient recovered.
Consumer or non-health professional from JAPAN reported BREVIBLOC problem on June 01, 2007. Male patient, 60 years of age, was diagnosed with blood pressure increased and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. BREVIBLOC dosage: unknown. During the same period patient was treated with NEOSTIGMINE, DIGOXIN, AMLODIPINE, LOSARTAN, FAMOTIDINE, NATEGLINIDE, ACARBOSE, NICARDIPINE HYDROCHLORIDE. Patient recovered.
BREVIBLOC problem was reported by a Consumer or non-health professional from JAPAN on June 22, 2007. Male patient, 60 years of age, weighting 145.5 lb, was diagnosed with tachycardia, blood pressure increased, neuromuscular blockade reversal, atrial fibrillation and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest. BREVIBLOC dosage: unknown. During the same period patient was treated with NEOSTIGMINE, DIGOXIN, FENTANEST, AMLODIPINE, LOSARTAN POTASSIUM, FAMOTIDINE, NATEGLINIDE. Patient recovered.
Physician from UNITED STATES reported BREVIBLOC problem on Aug 25, 2006. Female patient, 50 years of age, weighting 130.0 lb, was diagnosed with post procedural complication, tachycardia and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, bradycardia, hypotension, ventricular extrasystoles. BREVIBLOC dosage: 20 MG; ONCE; IV. During the same period patient was treated with MORPHINE, FENTANYL, ISOFLURANE. Patient died on 08/22/2006.
BREVIBLOC problem was reported by a Pharmacist from UNITED STATES on Dec 06, 2006. Female patient, 78 years of age, weighting 172.0 lb, was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: extravasation, infusion site erythema, infusion site swelling, skin necrosis. BREVIBLOC dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported BREVIBLOC problem on June 22, 2007. Male patient, 60 years of age, was diagnosed with blood pressure increased, neuromuscular blockade reversal, atrial fibrillation, anaesthesia and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest. BREVIBLOC dosage: unknown. During the same period patient was treated with NEOSTIGMINE, DIGOXIN, FENTANYL CITRATE, AMLODIPINE, LOSARTAN POTASSIUM, FAMOTIDINE. Patient recovered.
BREVIBLOC problem was reported by a Consumer or non-health professional from JAPAN on June 22, 2007. Male patient, 60 years of age, was diagnosed with blood pressure increased, neuromuscular blockade reversal, atrial fibrillation, anaesthesia and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bradycardia, cardiac arrest, depressed level of consciousness. BREVIBLOC dosage: unknown. During the same period patient was treated with NEOSTIGMINE, DIGOXIN, FENTANYL CITRATE, AMLODIPINE, LOSARTAN POTASSIUM, FAMOTIDINE. Patient recovered.
Health Professional from JAPAN reported BREVIBLOC problem on July 05, 2007. Male patient, 60 years of age, weighting 145.5 lb, was diagnosed with tachycardia, blood pressure increased, neuromuscular blockade reversal, atrial fibrillation and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest. BREVIBLOC dosage: unknown. During the same period patient was treated with NEOSTIGMINE, DIGOXIN, FENTANEST, AMLODIPINE, LOSARTAN POTASSIUM, FAMOTIDINE, NATEGLINIDE. Patient recovered.
BREVIBLOC problem was reported by a Consumer or non-health professional from JAPAN on July 05, 2007. Male patient, 60 years of age, was diagnosed with blood pressure increased, neuromuscular blockade reversal, atrial fibrillation, anaesthesia and was treated with BREVIBLOC. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest. BREVIBLOC dosage: unknown. During the same period patient was treated with NEOSTIGMINE, DIGOXIN, FENTANYL CITRATE, AMLODIPINE, LOSARTAN POTASSIUM, FAMOTIDINE. Patient recovered.